Etta Biotech X-Porator M1 GMP-Compliant Continuous-Flow Large-Scale Electroporation System

Overview

The Etta Biotech X-Porator M1 is a GMP-compliant, continuous-flow large-scale electroporation system engineered for clinical-grade cell therapy manufacturing. It operates on the principle of controlled square-wave electroporation—applying precisely timed, high-voltage electric pulses across a conductive fluid stream to transiently permeabilize cell membranes and enable efficient nucleic acid or ribonucleoprotein (RNP) delivery. Unlike batch-mode electroporators, the X-Porator M1 employs laminar flow hydrodynamics within a sterilizable, single-use microfluidic cartridge to ensure uniform field distribution, minimal thermal accumulation, and reproducible transfection efficiency across 10⁹–10¹⁰ cells per run. Designed specifically for autologous and allogeneic T-cell, NK-cell, and hematopoietic stem cell engineering, it bridges the gap between research-scale optimization (e.g., X-Porator H1) and closed, scalable production under current Good Manufacturing Practice (cGMP) conditions.

Key Features

• GMP-integrated architecture: Fully enclosed aluminum chassis with IP54-rated sealing, autoclavable external surfaces, and compatibility with vaporized hydrogen peroxide (VHP) and 70% ethanol decontamination protocols.
• Continuous-flow processing: Supports single-run volumes up to 100 mL with integrated peristaltic pumping, real-time flow rate monitoring (±2% accuracy), and pulse synchronization to volumetric throughput.
• Parameter transparency & tunability: Independent adjustment of voltage (100–1,200 V), pulse width (1–100 ms), number of pulses (1–10), and interval timing (100 ms–5 s); all parameters logged with timestamp and operator ID.
• Regulatory-ready hardware design: Built-in barcode scanner for consumable traceability, dual-channel temperature sensors (inlet/outlet), and integrated pressure monitoring to detect occlusion or leak events.
• Scalable performance validation: Demonstrated linear scalability from X-Porator H1 to M1 across multiple primary human immune cell types—maintaining ≥93.9% eGFP mRNA transfection efficiency in activated T cells and ≥83.2% B2M knockout efficiency via RNP delivery.

Sample Compatibility & Compliance

The X-Porator M1 accommodates suspension-adapted mammalian cells including PBMCs, CD3⁺/CD28-stimulated T cells, expanded NK cells, and CD34⁺ hematopoietic progenitors. Its disposable cartridge set is manufactured from USP Class VI-certified medical-grade PVC with hydrophobic, low-protein-binding inner surface treatment—optimized for >90% viable cell recovery post-electroporation. All consumables are terminally sterilized (γ-irradiation, 25 kGy), supplied in ISO Class 5 cleanroom-packaged kits, and qualified for use in ISO Class 5 (Grade A) environments under EU GMP Annex 1. Third-party biocompatibility testing confirms compliance with ISO 10993-1, -5, -10, -11, and -12, covering cytotoxicity, acute systemic toxicity, hemolysis, pyrogenicity, sensitization, and intracutaneous reactivity.

Software & Data Management

The embedded control software is validated per FDA 21 CFR Part 11 requirements and aligned with ICH GCP and EU Annex 11 expectations. It implements role-based three-tier access control (Operator, Supervisor, Administrator), full electronic audit trail (including parameter changes, run start/stop, user logins, and error events), and digital signature capability for electronic records. Raw data—including voltage waveforms, current traces, temperature logs, and flow metrics—are stored in vendor-neutral CSV and HDF5 formats. The system supports export to LIMS via ASTM E1578-compliant interfaces and includes optional integration with MES platforms for batch record linkage and electronic batch manufacturing record (eBMR) generation.

Applications

• Clinical-scale non-viral gene editing: CRISPR-Cas9 RNP delivery for B2M, TRAC, or PDCD1 knockout in allogeneic CAR-T/NK development.
• mRNA-based cell programming: High-efficiency IVT-mRNA transfection for transient expression of chimeric antigen receptors, cytokines, or safety switches.
• Process transfer & tech transfer: Seamless scale-up from benchtop (X-Porator H1) to GMP pilot line (X-Porator M1) without re-optimization of critical quality attributes (CQAs).
• Automated closed-system workflows: Integration with upstream activation systems (e.g., magnetic bead-based stimulation) and downstream washing/concentration modules (e.g., Sepax or Elutra-compatible interfaces).
• Regulatory filing support: Pre-validated platform suitable for inclusion in IND/IMPD submissions; master file documentation available upon request per FDA Master File guidelines.

FAQ

Is the X-Porator M1 compliant with both US FDA and EU EMA GMP requirements?

Yes—the system design, qualification documentation, and software validation package align with ICH Q5A(R2), Q5D, Q7, and Annex 1 of the EU Guide to Good Manufacturing Practice for Medicinal Products.
Can the system be qualified for use in an ISO Class 5 cleanroom environment?

Yes—hardware materials, surface finish, and consumable packaging meet ISO 14644-1 Class 5 requirements; full cleanroom compatibility testing reports are included in the Installation Qualification (IQ) package.
Does the system support process analytical technology (PAT) integration?

Yes—via analog/digital I/O ports and OPC UA protocol support, enabling real-time integration with PAT tools such as inline viability probes, pH/O₂ sensors, and Raman spectrometers.
What regulatory documentation is provided with the system?

Standard deliverables include URS, FRS, DQ/IQ/OQ/PQ protocols and reports, 21 CFR Part 11 validation summary, GMP risk assessment (ICH Q9), and biocompatibility test certificates.
Is remote diagnostics and software update capability available?

Yes—secure TLS 1.2-enabled remote support channel (opt-in only), with firmware updates delivered through digitally signed packages verified via SHA-256 checksum and RSA-2048 signature validation.